True Cell Type,Predicted Main Cell Type,Predicted Sub Cell Types,Possible Mixed Cell Types,Marker Number,Marker List,Iterations,Model,Provider,Tissue,Species,Additional Info,Conversation History
intestinal enteroendocrine cell,Neuroendocrine Cells,"Alpha-cell like (pancreatic islet), Enteroendocrine-like (L-cell, EC-cell)","Circulating Neuroendocrine Tumor Cells (CTCs), Contaminating Neuroendocrine Tissue",50,"GCG, PCSK1, AC090679.1, UCN3, PYY, INSL5, CHGA, LCN15, SCG2, FEV, CPLX2, NKX2-2, AL133325.3, C1orf127, LINC01014, SCGN, SLC18A1, SCG3, SCG5, TPH1, MARCH4, INSM1, RTN1, CRYBA2, SNAP25, CHGB, CRMP1, KCNB2, RFX6, AMER3, SLC32A1, CDK5R2, AVPR1B, VWA5B2, AC022893.2, ABCC8, RIMBP2, AL161658.1, COL2A1, CELF3, SCT, RIIAD1, SSTR5-AS1, RGS4, ARX, PRPH, INA, F5, AP003062.3, SLC5A8",1,google/gemini-2.5-flash,openrouter,large_intestine,human,Batch analysis via web interface,"Final Annotation Agent: As a professional computational biologist, I will now proceed with a comprehensive analysis to identify the cell type based on the provided ranked marker list from a human peripheral blood single-cell dataset. **Step 1: Analyze Marker Genes** I will examine the provided ranked marker list, focusing on the top markers as they represent the highest expression intensity. * **GCG (Glucagon):** A well-known hormone primarily produced by alpha cells of the pancreatic islets. Its presence in peripheral blood cells is highly unusual for typical immune or blood cell types. * **PCSK1 (Proprotein Convertase Subtilisin/Kexin Type 1):** Involved in the proteolytic processing of prohormones and proneuropeptides, including proglucagon. Highly expressed in neuroendocrine cells. * **AC090679.1, UCN3 (Urocortin 3), PYY (Peptide YY), INSL5 (Insulin-like 5), CHGA (Chromogranin A):** These are all strong markers for neuroendocrine cells. UCN3 is found in pancreatic islet cells (beta and alpha cells), PYY in enteroendocrine L-cells, and INSL5 in enteroendocrine L-cells. CHGA is a general marker for neuroendocrine cells. * **LCN15, SCG2 (Secretogranin II), FEV, CPLX2 (Complexin 2), NKX2-2 (NK2 Homeobox 2):** These further reinforce the neuroendocrine signature. NKX2-2 is a transcription factor crucial for pancreatic islet development and neuroendocrine differentiation. * **AL133325.3, C1orf127, LINC01014, SCGN (Secretagogin), SLC18A1 (Solute Carrier Family 18 Member A1 - Vesicular Monoamine Transporter 1, VMAT1), SCG3 (Secretogranin III), SCG5 (Secretogranin V):** More markers consistent with neuroendocrine cells, particularly those involved in hormone/neurotransmitter storage and secretion. SCGN is a calcium-binding protein found in neuroendocrine cells. SLC18A1 is involved in packaging monoamines into synaptic vesicles. * **TPH1 (Tryptophan Hydroxylase 1):** Rate-limiting enzyme in serotonin synthesis, found in enterochromaffin cells (a type of enteroendocrine cell). * **MARCH4, INSM1 (Insulinoma-associated 1):** INSM1 is a key transcription factor for neuroendocrine differentiation. * **RTN1, CRYBA2, SNAP25 (Synaptosomal-Associated Protein 25), CHGB (Chromogranin B), CRMP1, KCNB2, RFX6 (Regulatory Factor X6), AMER3, SLC32A1 (Solute Carrier Family 32 Member A1 - Vesicular GABA Transporter, VGAT):** SNAP25 is a core component of the SNARE complex, essential for neurotransmitter/hormone release in neurons and neuroendocrine cells. RFX6 is a transcription factor critical for pancreatic islet cell development. SLC32A1 is involved in GABA transport, suggesting a neuroendocrine or neuronal lineage. * **CDK5R2, AVPR1B, VWA5B2, AC022893.2, ABCC8 (ATP Binding Cassette Subfamily C Member 8), RIMBP2, AL161658.1, COL2A1, CELF3, SCT (Secretin), RIIAD1, SSTR5-AS1, RGS4, ARX (Aristaless Related Homeobox), PRPH (Peripherin), INA (Internexin Alpha), F5, AP003062.3, SLC5A8:** ABCC8 is part of the KATP channel, crucial for insulin secretion in pancreatic beta cells. SCT is a hormone produced by S cells in the duodenum. ARX is a transcription factor involved in pancreatic alpha cell development and neuronal differentiation. PRPH and INA are intermediate filament proteins found in neurons and neuroendocrine cells. **Summary of Marker Analysis:** The overwhelming majority of the highly expressed markers are classic indicators of neuroendocrine cells. Specifically, there's a strong enrichment for markers associated with pancreatic islet cells (GCG, PCSK1, NKX2-2, ABCC8, RFX6, ARX) and enteroendocrine cells (PYY, INSL5, TPH1, SCT). General neuroendocrine markers like CHGA, CHGB, SCG2, SCGN, SNAP25, INSM1, PRPH, and INA are also prominent. **Step 2: Consider Biological Context** * **Tissue Type: Peripheral Blood.** This is the critical piece of information. Typical peripheral blood contains immune cells (lymphocytes, monocytes, granulocytes), red blood cells, and platelets. It does *not* normally contain significant numbers of intact, functional neuroendocrine cells from organs like the pancreas or gut. * **Species: Human.** * **Additional Information: """"Batch analysis via web interface.""""** This suggests a standard scRNA-seq pipeline. The presence of such a strong neuroendocrine signature in a *peripheral blood* sample is highly anomalous. This immediately raises several possibilities: 1. **Contamination:** The sample might be contaminated with cells from another tissue (e.g., pancreatic tissue, gut tissue, or a neuroendocrine tumor). 2. **Circulating Tumor Cells (CTCs):** The patient might have a neuroendocrine tumor (e.g., pancreatic neuroendocrine tumor, carcinoid tumor) that is shedding cells into the bloodstream. These CTCs would express the markers of their tissue of origin. 3. **Rare Circulating Neuroendocrine Cells (Non-Malignant):** While extremely rare, some studies have reported the presence of very low numbers of non-malignant circulating cells from various organs. However, the high expression of these markers sugge... [truncated]"
plasma cell,Plasma Cell,"Plasmablast, Circulating Plasma Cell, Short-lived Plasma Cell",,50,"IGLL5, IGLV6-57, JCHAIN, FAM92B, IGLC3, IGLC2, IGHV3-7, IGKC, TNFRSF17, IGHG1, AC026369.3, IGHV3-23, IGKV4-1, IGKV1-5, IGHA1, IGLV3-1, IGLV2-11, MYL2, MZB1, IGHG3, IGHV3-74, IGHM, ANKRD36BP2, AMPD1, IGKV3-20, IGHA2, DERL3, AC104699.1, LINC02362, AL391056.1, LILRB4, CCL3, BMP6, UBE2QL1, LINC00309, AL133467.1, GPRC5D, FCRL5, DNAAF1, AP002852.1, AC007569.1, CXorf21, RNU1-85P, U62317.4, TXNDC5, LINC02384, CCR10, BFSP2, APOBEC3A, AC106897.1",1,google/gemini-2.5-flash,openrouter,large_intestine,human,Batch analysis via web interface,"Final Annotation Agent: As a professional computational biologist, I will meticulously analyze the provided ranked marker list from a human peripheral blood single-cell dataset to identify the cell type. **Step 1: Analyze Marker Genes** I will examine the provided ranked marker list carefully, focusing on the most highly expressed genes first, as they are typically the most indicative. * **IGLL5, IGLV6-57, JCHAIN, IGLC3, IGLC2, IGHV3-7, IGKC, IGHG1, IGHV3-23, IGKV4-1, IGKV1-5, IGHA1, IGLV3-1, IGLV2-11, IGHG3, IGHM, IGKV3-20, IGHA2:** This is an overwhelming presence of immunoglobulin (Ig) genes, including light chain variable (IGLV, IGKV), light chain constant (IGLC, IGKC), heavy chain variable (IGHV), and heavy chain constant (IGHG, IGHM, IGHA) genes. The presence of JCHAIN (joining chain) is also highly significant. These genes are the hallmark of B-lineage cells, specifically those actively producing and secreting antibodies. * **TNFRSF17 (BCMA):** B-cell maturation antigen. This is a key marker for plasma cells and plasmablasts, involved in their survival and differentiation. * **MZB1 (Marginal zone B and B1 cell specific protein):** While its name suggests marginal zone B cells, MZB1 is also highly expressed in plasma cells and plasmablasts, playing a role in protein secretion. * **GPRC5D:** G protein-coupled receptor class C group 5 member D. This is a known surface marker highly expressed on plasma cells, particularly in multiple myeloma. * **FCRL5 (Fc receptor-like 5):** Also known as CD307e. Expressed on B cells and plasma cells, particularly those involved in immune responses. * **DERL3 (Derlin 3):** Involved in ER-associated degradation (ERAD), which is highly active in cells with extensive protein synthesis and secretion, like plasma cells. * **CCL3 (MIP-1Î±):** While not exclusive, some plasma cells can produce chemokines. * **LILRB4 (CD85k):** Leukocyte immunoglobulin-like receptor B4. Expressed on myeloid cells, but also found on some B cell subsets and plasma cells. Its presence here is less specific than the Ig genes or TNFRSF17. * **MYL2 (Myosin Light Chain 2):** Typically associated with muscle cells. Its presence here is unusual for a hematopoietic cell and might indicate a low-level, non-specific expression, or potentially a very minor contaminant, or a gene with a less characterized role in this specific cell type. Given the overwhelming Ig signature, it's likely a minor or non-specific hit. * **FAM92B, AC026369.3, ANKRD36BP2, AMPD1, AC104699.1, LINC02362, AL391056.1, LINC00309, AL133467.1, AP002852.1, AC007569.1, CXorf21, RNU1-85P, U62317.4, TXNDC5, LINC02384, BFSP2, APOBEC3A, AC106897.1:** Many of these are uncharacterized loci, lincRNAs, or genes with less specific roles in immune cells. Their high ranking suggests they are highly expressed in this specific cell state, but without known specific immune functions, they are less informative for initial cell type identification compared to the canonical markers. * **BMP6 (Bone Morphogenetic Protein 6):** While BMPs have diverse roles, including in hematopoiesis, BMP6 is not a primary marker for a specific immune cell type in peripheral blood. * **UBE2QL1, DNAAF1, CCR10:** Less specific markers in this context. CCR10 is a chemokine receptor, but not a primary identifier here. **Step 2: Consider Biological Context** * **Tissue Type: Peripheral Blood (Human)**. This context is crucial. Peripheral blood contains various immune cells (T cells, B cells, NK cells, monocytes, neutrophils, etc.) and their subsets. Mature plasma cells are typically found in lymphoid organs (bone marrow, lymph nodes, spleen) and mucosal tissues, but a small number of circulating plasmablasts/plasma cells can be found in peripheral blood, especially during active immune responses or in certain disease states. * **Species: Human.** This ensures that the gene names and their known functions are directly applicable. **Step 3: Formulate Hypotheses** Based on the strong evidence from Step 1 and considering the biological context: 1. **Hypothesis 1 (Most Likely): Plasma Cells / Plasmablasts.** The overwhelming expression of immunoglobulin genes (variable and constant regions for heavy and light chains), JCHAIN, TNFRSF17 (BCMA), MZB1, and GPRC5D are all highly characteristic of antibody-secreting cells. Plasmablasts are circulating precursors to plasma cells, and both are characterized by high Ig production. Given the peripheral blood context, these are likely circulating plasmablasts or short-lived plasma cells. 2. **Hypothesis 2 (Less Likely, but related): Activated B Cells.** While activated B cells do express Ig genes, the sheer volume and diversity of Ig chain expression, coupled with the presence of JCHAIN, TNFRSF17, MZB1, and GPRC5D, point more strongly towards a terminally differentiated, antibody-secreting cell state rather than a typical activated B cell. Activated B cells would typically also express higher levels of B cell receptor components (e.g., CD19, CD20... [truncated]"
transit amplifying cell of large intestine,Proliferating Cells,"Cells in S phase, Cells in G2 phase, Cells in M phase, Hematopoietic Stem and Progenitor Cells (HSPCs)","Activated Lymphocytes, Circulating Malignant Cells",50,"HJURP, UBE2C, CENPA, PBK, AURKB, DLGAP5, CKAP2L, KIF2C, KIF15, BIRC5, SPC25, ASPM, KIF18B, CEP55, DEPDC1, MKI67, CDC45, CDCA5, TOP2A, PCLAF, MND1, RRM2, ZNF695, CCNB2, NUF2, SKA3, SPC24, DTL, PKMYT1, CDCA3, TTK, DIAPH3, PLK1, IQGAP3, CDK1, TK1, POLQ, GTSE1, OIP5, FOXM1, TROAP, SKA1, NEK2, CDC25C, NCAPG, PIMREG, GINS2, RAD51AP1, CDT1, CCNA2",1,google/gemini-2.5-flash,openrouter,large_intestine,human,Batch analysis via web interface,"Final Annotation Agent: As a professional computational biologist, I will now proceed with a comprehensive analysis to identify the cell type based on the provided ranked marker list from a human peripheral blood single-cell dataset. **Step 1: Analyze Marker Genes** I will examine the provided ranked marker list, which is ordered by expression intensity from high to low. * **HJURP, UBE2C, CENPA, PBK, AURKB, DLGAP5, CKAP2L, KIF2C, KIF15, BIRC5, SPC25, ASPM, KIF18B, CEP55, DEPDC1, MKI67, CDC45, CDCA5, TOP2A, PCLAF, MND1, RRM2, ZNF695, CCNB2, NUF2, SKA3, SPC24, DTL, PKMYT1, CDCA3, TTK, DIAPH3, PLK1, IQGAP3, CDK1, TK1, POLQ, GTSE1, OIP5, FOXM1, TROAP, SKA1, NEK2, CDC25C, NCAPG, PIMREG, GINS2, RAD51AP1, CDT1, CCNA2** Upon initial inspection, a striking pattern emerges: the vast majority of these genes are well-established markers of cell proliferation and cell cycle progression. Let's break down some key markers: * **MKI67 (Ki-67):** This is a classic and highly reliable marker for proliferating cells. Its presence is almost always indicative of cells actively undergoing division. * **TOP2A (DNA Topoisomerase II Alpha):** Involved in DNA replication and chromosome segregation during mitosis. * **CDK1 (Cyclin-Dependent Kinase 1):** A master regulator of cell cycle progression, particularly entry into mitosis. * **CCNB2 (Cyclin B2), CCNA2 (Cyclin A2):** Cyclins are key regulators of CDK activity and cell cycle progression. * **AURKB (Aurora Kinase B):** Critical for chromosome segregation and cytokinesis. * **BIRC5 (Survivin):** An anti-apoptotic protein highly expressed in proliferating cells, involved in cell division. * **KIF2C, KIF15, KIF18B (Kinesin Family Members):** Many kinesins are involved in spindle formation and chromosome movement during mitosis. * **CENPA (Centromere Protein A):** A histone H3 variant specific to centromeres, crucial for kinetochore assembly and chromosome segregation. * **PBK (PDZ Binding Kinase):** Involved in cell cycle regulation and mitosis. * **DLGAP5 (DLG Associated Protein 5):** Involved in spindle organization and cytokinesis. * **ASPM (Abnormal Spindle Microtubule Assembly):** Essential for normal spindle function and cell division. * **CEP55 (Centrosomal Protein 55):** Involved in cytokinesis. * **FOXM1 (Forkhead Box M1):** A transcription factor that regulates the expression of many genes involved in cell cycle progression and mitosis. * **TK1 (Thymidine Kinase 1):** Involved in DNA synthesis, highly expressed in S-phase. * **RRM2 (Ribonucleotide Reductase M2):** Essential for DNA synthesis. * **PLK1 (Polo-like Kinase 1):** A key regulator of multiple mitotic events. * **CDC45, CDC25C, CDT1:** Cell division cycle proteins, crucial for DNA replication and cell cycle transitions. * **GINS2, RAD51AP1:** Involved in DNA replication and repair. The overwhelming majority of these markers are directly associated with the cell cycle, DNA replication, mitosis, and cell proliferation. There are no clear markers for specific mature immune cell types (e.g., CD3 for T cells, CD19 for B cells, CD14 for monocytes, CD16 for NK cells, CD68 for macrophages, CD1c for dendritic cells, etc.). **Step 2: Consider Biological Context** * **Tissue Type: Peripheral Blood (Human)**: Peripheral blood is a complex tissue containing various mature immune cells (T cells, B cells, NK cells, monocytes, granulocytes), as well as a small population of hematopoietic stem and progenitor cells (HSPCs) and circulating tumor cells (if present in disease states). * **Species: Human**: The gene names are standard human gene symbols. * **Biological Plausibility**: In healthy peripheral blood, mature immune cells are largely quiescent (non-proliferating). However, there are always a small number of circulating progenitor cells, and in certain physiological or pathological conditions (e.g., infection, inflammation, hematological malignancies), immune cells can become activated and proliferate, or immature/proliferating cells might be released into circulation. Given the strong proliferative signature, we must consider cell types that are actively dividing. **Step 3: Formulate Hypotheses** Based on the strong and consistent proliferative signature, I will formulate the following hypotheses: 1. **Hypothesis 1: Proliferating Cells (General)**: This cluster represents a population of cells that are actively undergoing cell division, regardless of their specific lineage. This is the most direct interpretation of the marker list. * *Likelihood:* Very High. The markers are unequivocally linked to proliferation. 2. **Hypothesis 2: Hematopoietic Stem and Progenitor Cells (HSPCs)**: HSPCs are inherently proliferative and reside in the bone marrow but can circulate in peripheral blood, especially after mobilization or in certain disease states. They are the source of all mature blood cells. * *Likelihood:* High. This is a plausible source of proliferating cells in peripheral blood. While specific HSPC markers (e.g., CD34, CD38,... [truncated]"
